COMMUNIQUÉS West-GlobeNewswire

Elite Pharmaceuticals Announces Strategic Marketing Alliance with Glenmark Pharmaceuticals, Inc., USA
29/05/2018
NORTHVALE, N.J., May 29, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc (OTCBB: ELTP ) announced today the signing of a license, manufacturing, and supply agreement with Glenmark Pharmaceuticals, Inc., USA to [...]
Evolus Appoints Veteran Healthcare Executive Lauren Silvernail as Chief Financial Officer and Executive Vice President, Corporate Development
29/05/2018
IRVINE, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS ) (“Evolus” or the “Company”), a premiere aesthetics company, today announced the appointment of Lauren Silvernail as Chief Financial Officer [...]
Insider's tradings
29/05/2018
Nasdaq Copenhagen 29 May 2018 Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation art. 19 Coloplast is obliged to report on the [...]
Bellicum Pharmaceuticals Appoints Shane Ward as General Counsel
29/05/2018
HOUSTON, May 29, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM ), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]
Microbot Medical Announces Successful Completion of Pre-Clinical Study Performed at Washington University in St. Louis
29/05/2018
Significant Milestone Suggests Initial Safety Profile of the Self-Cleaning Shunt (SCS™) Product as the Company Moves Forward to Next Development Phase HINGHAM, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- Microbot Medical [...]
Allergy Therapeutics plc - Positive new data with house-dust mite immunotherapy
29/05/2018
Al l ergy Therapeutics plc ("Allergy Therapeutics", the “Group” or “Company") Positive new clinical data with house-dust mite immunotherapy ~ House-dust mite immunotherapy shown to be well-tolerated and demonstrates [...]
Capricor Therapeutics to Present at the 2018 BIO International Convention in Boston
29/05/2018
LOS ANGELES, May 29, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ), a biotechnology company developing biological therapies for Duchenne muscular dystrophy and other rare disorders, today announced that [...]
Codexis to Present at Three Upcoming Investment Conferences
29/05/2018
REDWOOD CITY, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS ), a leading protein engineering company, announces that management will present at three upcoming investment conferences: 15 th Annual [...]
Brainsway Reports Record Financial Results for First Quarter of 2018 and Provides Corporate Update
29/05/2018
First quarter revenues of $3.6 million represent a quarterly record and a 68% increase over first quarter 2017 Increased market demand and leasing model continue to generate sales growth HACKENSACK, N.J., May 29, 2018 ( [...]
Nabriva Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
29/05/2018
DUBLIN, Ireland and KING OF PRUSSIA, Pa., May 29, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV ), a clinical stage biopharmaceutical company engaged in the research and development of novel anti- [...]
Antares Pharma to Present at the Jefferies 2018 Healthcare Conference
29/05/2018
EWING, N.J., May 29, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Jefferies 2018 Healthcare Conference on [...]
Axsome Therapeutics to Present Data on AXS-05 at the 2018 American Society of Clinical Psychopharmacology Annual Meeting
29/05/2018
NEW YORK, May 29, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM ), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]
Neuralstem to Participate at the BIO 2018 International Convention
29/05/2018
GERMANTOWN, Md., May 29, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq: CUR ), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that Karl Johe, PhD, Chief [...]
Akcea Therapeutics to Present at the Jefferies Global Healthcare Conference
29/05/2018
CAMBRIDGE, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc.(NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc., today announced that management will present a company overview at the Jefferies [...]
Aileron Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
29/05/2018
CAMBRIDGE, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN ), the leader in the field of stapled peptide therapeutics for cancers and other diseases, today announced that Manuel Aivado, CMO [...]
Milestone Scientific Announces Two Additional Independent Distributors in the U.S. for CompuFlo® Epidural System
29/05/2018
Agreements cover territories within the Northwest and Mid-Atlantic Regions LIVINGSTON, N.J., May 29, 2018 (GLOBE NEWSWIRE) -- Milestone Scientific Inc . (NYSE: MLSS ), a leading developer of computerized drug delivery [...]
AxoGen, Inc. Announces Repayment in Full of its $25 million Outstanding Debt
29/05/2018
ALACHUA, Fla., May 29, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, announced that it repaid in full its [...]
Amunix announces report by Bioverativ on unprecedented half-life obtained in patients treated with a novel, long-acting FVIII utilizing Amunix’s XTEN® technology
29/05/2018
MOUNTAIN VIEW, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- Amunix Operating Inc. is pleased to report that Bioverativ (a Sanofi company) has announced preliminary Phase 1/2a safety and pharmacokinetic clinical data for [...]
Axovant Strengthens Management Team and Completes Organizational Restructuring in Preparation for Pipeline Expansion
29/05/2018
Gavin Corcoran, current Chief Medical Officer of Allergan plc, to join Axovant as EVP of R&D Michael Hayden, former Chief Scientific Officer and President of Global R&D at Teva, to serve as Chairman of Axovant’s [...]

Pages